Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.
Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.
Dakota centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.
Below is today’s list of five PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.
Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.
Sourced from Dakota Sponsor Backed Companies.
1. Red Sky Health Corporation
Red Sky Health Corporation is a privately held company specializing in healthcare claims management, focusing on automating the remediation of health insurance claim denials. Their primary product, Daniel, is an AI-driven platform that utilizes machine learning to analyze denied claims, identify issues, and provide real-time fixes, thereby streamlining the resubmission process for healthcare providers. The company serves healthcare providers seeking to recover revenue lost due to claim denials.
-
Sector: Health Care
-
Industry: Health Care Technologies
-
Last known transaction date: Seed Round, $3.35M, announced in May 2025
-
Major sponsors/backers: Davidovs Venture Collective
-
Why timing suggests a near-term transaction: Red Sky Health Corporation’s $3.35M seed round announced in May 2025 places the company roughly 12–18 months removed from its initial institutional financing by mid to late 2026. At this stage, venture-backed healthcare startups often begin evaluating follow-on capital, strategic partnerships, or early acquisition interest, particularly as clinical validation, customer traction, and commercialization plans take shape.
2. Nilus
Nilus is an AI-powered treasury management platform founded in 2021 by Daniel Kalish and Danielle Shaul. The company is headquartered in New York, NY, and specializes in providing real-time visibility into cash flow, AI-driven forecasting, and automated cash reconciliation for finance teams. Nilus aims to simplify treasury operations and enhance financial decision-making for businesses ranging from midsize companies to publicly traded firms. Its customer base includes Alloy, Taboola, Made In Cookware, and Planned Parenthood. The platform integrates data from various sources, including banks, payment systems, billing, and ERPs, to offer comprehensive cash management solutions.
-
Sector: Information Technology
-
Industry: Software
-
Last known transaction date: Series A, $10M announced in January 2025.
-
Major sponsors/backers: Led by Felicis and Vesey Ventures, with participation from existing investor Bessemer Venture Partners
-
Why timing suggests a near-term transaction: Nilus’ $10M Series A announced in January 2025 places the company roughly 12–18 months removed from its most recent financing by mid to late 2026. At this stage, venture-backed fintech and enterprise software platforms often begin exploring follow-on growth capital, strategic partnerships, or early acquisition interest, particularly as product adoption, revenue traction, and enterprise integrations continue to scale.
3. Tricares
TRiCares is a medical device company specializing in the development of catheter-based valve replacement systems for the minimally invasive treatment of tricuspid regurgitation (TR). Founded in 2013 and headquartered in Paris, France, the company aims to address the unmet clinical need for effective TR treatments by offering a less invasive alternative to open-heart surgery.
-
Sector: Health Care
-
Industry: Health Care Equipment
-
Last known funding round: Series D, $50M, announced July 2024
-
Major sponsors/backers: Single strategic investor
-
Why timing suggests a near-term transaction: Tricare’s $50M Series D announced in July 2024 places the company approximately 18–24 months removed from its most recent financing by early to mid-2026. At this stage, venture-backed, late-stage platforms often see increased activity around strategic capital, secondary liquidity, or acquisition discussions, as scale, operating leverage, and longer-term exit pathways become clearer.
4. Muon Space
Muon Space is a space systems company specializing in designing, building, and operating low Earth orbit (LEO) satellite constellations for Earth intelligence missions. Their integrated technology stack, Muon Halo™, enables rapid deployment and superior constellation performance, providing critical data for applications such as environmental monitoring, disaster response, and climate research.
-
Major sponsors/backers: Activate Capital Partners, Radical Ventures, Costanoa Ventures, Congruent Ventures, ACME Capital
-
Why timing suggests a near-term transaction: Muon Space’s $56.7M Series B announced in August 2024 places the company roughly 18 months removed from its most recent financing by early 2026. At this point, venture-backed aerospace and advanced technology platforms often begin evaluating follow-on growth capital, strategic partnerships, or acquisition interest, particularly as program execution, customer contracts, and long-term commercial visibility continue to mature.
5. David AI
David AI is an audio data research company specializing in creating high-quality, non-publicly available audio datasets to advance voice AI applications. Their datasets support various AI labs and companies in developing speech recognition, translation, synthesis, and conversational AI systems.
-
Major sponsors/backers: Led by First Round Capital, with participation from BoxGroup, Y Combinator, SV Angel, and Liquid 2 Ventures.
-
Why timing suggests a near-term transaction: David AI’s $5M seed round announced in January 2025 places the company approximately 12–18 months removed from its initial financing by mid to late 2026. At this point, venture-backed technology companies often begin preparing for a follow-on growth round, strategic partnerships, or early acquisition discussions, as product validation, early customer adoption, and commercial momentum become clearer.
Use Dakota’s Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does
Dakota’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.
Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.
Fully integrated into Dakota Marketplace, this dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.
To explore more companies likely to transact, book a demo of Dakota Marketplace!
